Copyright © 2000 by the European Society of Cardiology.
Mortality and repeat interventions up until 20 years after aorto-coronary bypass surgery with saphenous vein grafts. A follow-up study of 1041 patients
a Division of Cardiology, Thorax Center of the Academic Hospital Rotterdam "Dijkzigt" Rotterdam, The Netherlands
b Division of Cardio-Pulmonary Surgery, Thorax Center of the Academic Hospital Rotterdam "Dijkzigt" Rotterdam, The Netherlands
revised July 14, 1999; accepted July 22, 1999
Abstract
Aims To determine very long-term survival and incidence of recurrent interventions following aorto-coronary bypass surgery using venous grafts.
Methods and Results A group of 1041 consecutive patients operated upon between 1971 and 1980 were followed for a median of 19 years (range 13–26). Peri-operative mortality was 1·2%. Survival probability at 5, 10, 15, and 20 years was 92%, 77%, 57%, and 40%, respectively. After 5 or more years following operation the mortality was higher than in the matched Dutch population. Age, extent of coronary artery disease, and ejection fraction are independent predictors of mortality. Of the 593 deceased patients at least 63% died of a probable cardiac cause, while cardiovascular mortality is 40% in the general Dutch population. Repeat revascularization procedures (aorto-coronary bypass surgery or percutaneous transluminal coronary angioplasty) were performed in 343 patients (33%), with an increasing incidence after 7 years.
Conclusion Aorto-coronary bypass surgery using vein grafts is safe and has a reasonable long-term prognosis for survival, although less than a matched population. After approximately 7 years both mortality and the need for repeated revascularizations increased. Since a majority of patients died of a cardiac cause and a substantial number of patients required repeated revascularization, aorto-coronary bypass surgery is a palliative treatment of a progressive disease.
Key Words: Coronary artery bypass surgery, survival, cause of death, repeat interventions, percutaneous transluminal coronary angioplasty
f1 Correspondence: Dr Rolf F. Veldkamp, Division of Cardiology, Thorax Center, Academic Hospital Rotterdam "Dijkzigt", Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
References
- Anonymous. ACC/AHA guidelines and indications for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on coronary artery bypass graft surgery). Circulation. 1991;83:1125–1173
[Free Full Text] - Califf M, Harrel FE, Lee KL. The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. JAMA. 1989;261:2077–2086[Abstract]
- Yusuf S, Zucker D, Peduzzi P. Effect of coronary artery bypass graft surgery on survival. Overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563–570[CrossRef][ISI][Medline]
- Laird-Meeter, K, Results of ten years aorto-coronary bypass surgery at the Thoraxcenter, Rotterdam, Erasmus University Rotterdam, 1983
- Ruygrok P, de Jaegere PPT, van Domburg RT. Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients. J Am Coll Cardiol. 1996;27:1669–1677[Abstract]
- Unger F. The changing image in cardiac surgery. J Cardiovasc Surg (Torino). 1994;35:1–5
- Weintraub WS, Wenger NK, Jones EL, Craver JM, Guyton RA. Changing clinical characteristics of coronary surgery patients. Differences between men and women. Circulation. 1993;88:79–86
- Lytle BW, Loop FD, Cosgrove DM, Ratcliff NB, Easley K, Taylor PC. Long term (5–12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 1985;89:248–258[Abstract]
- Campeau L, Enjalabert M, Lesperance J. The relation of risk factors to the development of atherosclerosis in saphenous- vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med. 1984;311:1329–1332[Abstract]
- Loop FD, Lytle BW, Cosgrove DM. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1–6[Abstract]
- Angelini GD, Newby AC. The future of saphenous vein as coronary artery bypass conduit. Eur Heart J. 1989;10:273–280
[Abstract/Free Full Text] - Laird-Meeter K, Penn OCKM, Haalebos MMP. Survival in 1041 patients with consecutive aorto-coronary bypass operations. Eur Heart J. 1984;5:35–42
[Abstract/Free Full Text] - Laird-Meeter K, van Domburg R, Bos E, Hugenholtz PG. Survival at 5 to 10 years after aorto-coronary bypass operations in 1041 consecutive patients. Eur Heart J. 1987;8:449–456
[Abstract/Free Full Text] - Veldkamp RF, Baartman GJ, van Domburg R, Tijssen JGP, Bos E, Meeter K. Overleving 11 jaar na een aorto-coronaire bypass-operatie. Ned Tijdschr Geneeskd. 1991;135:1229–1232[Medline]
- Ulicny KS, Flege JB, Callard GM, Todd JC. Twenty-year follow-up of saphenous vein aortocoronary artery bypass grafting. Ann Thorac Surg. 1992;53:258–262[Abstract]
- Rahimtoola SH, Fessler CL, Grunkemeier GL, Starr A. Survival 15 to 20 years after coronary bypass surgery for angina. J Am Coll Cardiol. 1993;21:151–157[Abstract]
- van Brussel BL, Ernst JNTG, Ernst NM. Clinical outcome in venous coronary artery bypass grafting: a 15-year follow-up study. Int J Cardiol. 1997;58:119–126[CrossRef][ISI][Medline]
- Hammar N, Sandberg E, Larsen FF, Ivert T. Comparison of early and late mortality in men and women after isolated coronary artery bypass graft surgery in Stockholm, Sweden, 1980 to 1989. J Am Coll Cardiol. 1997;29:659–664[Abstract]
- Anonymous, Hart en vaatziekten in Nederland 1996, 1996
- Lawrie GM, Morris GC, Earle N. Long-term results of coronary bypass surgery. Analysis of 1698 patients followed 15 to 20 years. Ann Surg. 1991;213:377–385[ISI][Medline]
- Sergeant P, Lesaffre E, Flameng W, Suy R, Blackstone E. The return of clinically evident ischemia after coronary artery bypass grafting. Eur J Cardiothorac Surg. 1991;5:447–457[Abstract]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R.T van Domburg, D.P Foley, A Breeman, L.A van Herwerden, and P.W Serruys Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. Twenty-year clinical outcome Eur. Heart J., April 1, 2002; 23(7): 543 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.T. van Domburg, J.J.M. Takkenberg, L.A. van Herwerden, A.C. Venema, and A.J.J.C. Bogers Short-term and 5-year outcome after primary isolated coronary artery bypass graft surgery: results of risk stratification in a bilocation center Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 733 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.T van Domburg, D.P Foley, P.J de Feyter, W van der Giessen, M.J.B.M van den Brand, and P.W Serruys Long-term clinical outcome after coronary balloon angioplasty. Identification of a population at low risk of recurrent events during 17 years of follow-up Eur. Heart J., June 1, 2001; 22(11): 934 - 941. [Abstract] [PDF]
|
|
|
|
|
|
P.J. de Feyter The fatal attraction of saphenous venous bypass grafts Eur. Heart J., May 1, 2000; 21(9): 697 - 698. [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||